170 related articles for article (PubMed ID: 33622345)
1. Can internal mammary lymph nodes irradiation bring survival benefits for breast cancer patients? A systematic review and meta-analysis of 12,705 patients in 12 studies.
Jia S; Liu Z; Zhang J; Zhao C; Zhu L; Kong J; Han H; Shang Y; Shen D; Duan X
Radiat Oncol; 2021 Feb; 16(1):42. PubMed ID: 33622345
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival outcomes following internal mammary node irradiation in stage II-III breast cancer: results of a large retrospective study with 12-year follow-up.
Chang JS; Park W; Kim YB; Lee IJ; Keum KC; Lee CG; Choi DH; Suh CO; Huh SJ
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):867-72. PubMed ID: 23747215
[TBL] [Abstract][Full Text] [Related]
3. DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer.
Thorsen LB; Offersen BV; Danø H; Berg M; Jensen I; Pedersen AN; Zimmermann SJ; Brodersen HJ; Overgaard M; Overgaard J
J Clin Oncol; 2016 Feb; 34(4):314-20. PubMed ID: 26598752
[TBL] [Abstract][Full Text] [Related]
4. Internal mammary node irradiation improves 8-year survival in breast cancer patients: results from a retrospective cohort study in real-world setting.
Wang X; Luo J; Jin K; Chen X; Zhang L; Meng J; Zhang X; Zhang Z; Shao Z; Bazan JG; Guo X; Yang Z; Yu X
Breast Cancer; 2020 Mar; 27(2):252-260. PubMed ID: 31696449
[TBL] [Abstract][Full Text] [Related]
5. Effect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast Cancer: A Randomized Phase 3 Clinical Trial.
Kim YB; Byun HK; Kim DY; Ahn SJ; Lee HS; Park W; Kim SS; Kim JH; Lee KC; Lee IJ; Kim WT; Shin HS; Kim K; Shin KH; Nam CM; Suh CO
JAMA Oncol; 2022 Jan; 8(1):96-105. PubMed ID: 34695841
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Internal Mammary Nodes is Associated With Improved Overall Survival in Breast Cancer: A Meta-Analysis.
Shaikh PM; Mulherkar R; Khasawneh MT; Clump D; Hazard-Jenkins H; Hafez M; Vargo JA
Am J Clin Oncol; 2024 Feb; 47(2):81-87. PubMed ID: 37916961
[TBL] [Abstract][Full Text] [Related]
7. Internal Mammary Node Irradiation in Patients With Node-Positive Early Breast Cancer: Fifteen-Year Results From the Danish Breast Cancer Group Internal Mammary Node Study.
Thorsen LBJ; Overgaard J; Matthiessen LW; Berg M; Stenbygaard L; Pedersen AN; Nielsen MH; Overgaard M; Offersen BV;
J Clin Oncol; 2022 Dec; 40(36):4198-4206. PubMed ID: 35394824
[TBL] [Abstract][Full Text] [Related]
8. Does internal mammary node irradiation affect treatment outcome in clinical stage II-III breast cancer patients receiving neoadjuv ant chemotherapy?
Kim KH; Noh JM; Kim YB; Chang JS; Keum KC; Huh SJ; Choi DH; Park W; Suh CO
Breast Cancer Res Treat; 2015 Aug; 152(3):589-99. PubMed ID: 26202053
[TBL] [Abstract][Full Text] [Related]
9. Internal mammary node irradiation in node-positive breast cancer treated with mastectomy and taxane-based chemotherapy.
Cho WK; Chang JS; Park SG; Kim N; Choi DH; Kim H; Kim YB; Park W; Suh CO
Breast; 2021 Oct; 59():37-43. PubMed ID: 34126377
[TBL] [Abstract][Full Text] [Related]
10. Internal Mammary Node Irradiation (IMNI) Improves Survival Outcome for Patients With Clinical Stage II-III Breast Cancer After Preoperative Systemic Therapy.
Luo J; Jin K; Chen X; Wang X; Yang Z; Zhang L; Mei X; Ma J; Zhang X; Zhou Z; Wang X; Jiang Y; Shao Z; Zhang Z; Guo X; Yu X
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):895-904. PubMed ID: 30439485
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of the Addition of Internal Mammary Irradiation to Standard Adjuvant Radiation in Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis.
Korzets Y; Levitas D; Grubstein A; Corn BW; Amir E; Goldvaser H
Curr Oncol; 2022 Sep; 29(9):6657-6673. PubMed ID: 36135092
[TBL] [Abstract][Full Text] [Related]
12. The optimal regional irradiation volume for breast cancer patients: A comprehensive systematic review and network meta-analysis of published studies.
Qi WX; Cao L; Xu C; Cai G; Chen J
Front Oncol; 2023; 13():1081201. PubMed ID: 36798812
[TBL] [Abstract][Full Text] [Related]
13. IMNI PRECISION trial protocol: a phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancer.
Qi WX; Cao L; Zheng S; Xu C; Cai R; Xu H; Cai G; Chen J
BMC Cancer; 2022 Dec; 22(1):1356. PubMed ID: 36575421
[TBL] [Abstract][Full Text] [Related]
14. Utilization patterns and temporal trends of internal mammary nodal irradiation at a tertiary cancer center.
Misra S; Lee G; Maganti M; Koch CA
Breast Cancer Res Treat; 2020 Jul; 182(2):367-379. PubMed ID: 32474745
[TBL] [Abstract][Full Text] [Related]
15. Toxicity of internal mammary irradiation in breast cancer. Are concerns still justified in times of modern treatment techniques?
Borm KJ; Simonetto C; Kundrát P; Eidemüller M; Oechsner M; Düsberg M; Combs SE
Acta Oncol; 2020 Oct; 59(10):1201-1209. PubMed ID: 32619381
[TBL] [Abstract][Full Text] [Related]
16. Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.
Courdi A; Chamorey E; Ferrero JM; Hannoun-Lévi JM
Radiother Oncol; 2013 Aug; 108(2):259-65. PubMed ID: 23891092
[TBL] [Abstract][Full Text] [Related]
17. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
18. Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial.
Poortmans PM; Weltens C; Fortpied C; Kirkove C; Peignaux-Casasnovas K; Budach V; van der Leij F; Vonk E; Weidner N; Rivera S; van Tienhoven G; Fourquet A; Noel G; Valli M; Guckenberger M; Koiter E; Racadot S; Abdah-Bortnyak R; Van Limbergen EF; Engelen A; De Brouwer P; Struikmans H; Bartelink H;
Lancet Oncol; 2020 Dec; 21(12):1602-1610. PubMed ID: 33152277
[TBL] [Abstract][Full Text] [Related]
19. A retrospective analysis on metastatic rate of the internal mammary lymph node and its clinical significance in adjuvant radiotherapy of breast cancer patients.
Li L; Zhang H; Wang L; Xie C; Zhou Y; Zhong Y
BMC Cancer; 2020 Feb; 20(1):153. PubMed ID: 32093638
[TBL] [Abstract][Full Text] [Related]
20. Individual case review in a phase 3 randomized trial to investigate the role of internal mammary lymph node irradiation for breast cancer: Korean Radiation Oncology Group 08-06 study.
Yoon HI; Yoon J; Chung Y; Nam CM; Cha H; Choi J; Lee J; Han HJ; Cho Y; Kim YB; Suh CO
Radiother Oncol; 2017 Apr; 123(1):15-21. PubMed ID: 28236539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
